Marshall Wace, LLP Biodesix Inc Transaction History
Marshall Wace, LLP
- $74.4 Billion
- Q1 2025
A detailed history of Marshall Wace, LLP transactions in Biodesix Inc stock. As of the latest transaction made, Marshall Wace, LLP holds 88,126 shares of BDSX stock, worth $35,250. This represents 0.0% of its overall portfolio holdings.
Number of Shares
88,126
Previous 15,058
485.24%
Holding current value
$35,250
Previous $22,000
150.0%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding BDSX
# of Institutions
64Shares Held
47.7MCall Options Held
65.5KPut Options Held
500-
Telemark Asset Management, LLC Boston, MA8.28MShares$3.31 Million0.75% of portfolio
-
Bryn Mawr Trust CO Bryn Mawr, PA6.1MShares$2.44 Million0.03% of portfolio
-
Birchview Capital, LP Burlington, VT5.74MShares$2.29 Million3.25% of portfolio
-
Silverarc Capital Management, LLC4.1MShares$1.64 Million0.63% of portfolio
-
Monashee Investment Management LLC Boston, MA4.05MShares$1.62 Million0.35% of portfolio
About BIODESIX INC
- Ticker BDSX
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 39,982,000
- Market Cap $16M
- Description
- Biodesix, Inc. operates as a data-driven diagnostic solutions company in the United States. The company offers blood-based lung tests, including Nodify XL2 and Nodify CDT tests, together marketed as part of Nodify Lung Nodule Risk Assessment testing strategy, to assess the risk of lung cancer and help in identifying the appropriate treatment pat...